This article first appeared on GuruFocus.

Evotec SE (NASDAQ:EVO) is set to release its Q3 2025 earnings on Nov 5, 2025. The consensus estimate for Q3 2025 revenue is $220.93 million, and the earnings are expected to come in at -$0.19 per share. The full year 2025's revenue is expected to be $892.43 million and the earnings are expected to be -$0.56 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 4 Warning Signs with EVO.

Is EVO fairly valued? Test your thesis with our free DCF calculator.

Revenue estimates for Evotec SE (NASDAQ:EVO) have declined from $957.23 million to $892.43 million for the full year 2025 and from $1.05 billion to $939.46 million for 2026 over the past 90 days. Earnings estimates have increased from -$0.61 per share to -$0.56 per share for the full year 2025. However, they have declined from -$0.24 per share to -$0.47 per share for 2026 over the past 90 days.

In the previous quarter of 2025-06-30, Evotec SE's (NASDAQ:EVO) actual revenue was $197.25 million, which missed analysts' revenue expectations of $236.31 million by -16.53%. Evotec SE's (NASDAQ:EVO) actual earnings were -$0.14 per share, which beat analysts' earnings expectations of -$0.16 per share by 12.10%. After releasing the results, Evotec SE (NASDAQ:EVO) was flat in one day.

Based on the one-year price targets offered by 2 analysts, the average target price for Evotec SE (NASDAQ:EVO) is $5.96 with a high estimate of $6.95 and a low estimate of $4.97. The average target implies an upside of 48.60% from the current price of $4.01.

Based on GuruFocus estimates, the estimated GF Value for Evotec SE (NASDAQ:EVO) in one year is $8.64, suggesting an upside of 115.46% from the current price of $4.01.

Based on the consensus recommendation from 3 brokerage firms, Evotec SE's (NASDAQ:EVO) average brokerage recommendation is currently 2.7, indicating a \\"Hold\\" status. The rating scale ranges from 1 to 5, where 1 signifies strong buy, and 5 denotes sell.